 Eosinophils
"Eosinophils" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.
| Descriptor ID |
D004804
|
| MeSH Number(s) |
A11.118.637.415.345 A11.627.340.345 A15.145.229.637.415.345 A15.382.490.315.251
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Eosinophils".
Below are MeSH descriptors whose meaning is more specific than "Eosinophils".
This graph shows the total number of publications written about "Eosinophils" by people in this website by year, and whether "Eosinophils" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 | | 1997 | 2 | 2 | 4 | | 1998 | 0 | 2 | 2 | | 1999 | 1 | 2 | 3 | | 2000 | 4 | 2 | 6 | | 2001 | 1 | 2 | 3 | | 2002 | 3 | 4 | 7 | | 2003 | 2 | 4 | 6 | | 2004 | 2 | 6 | 8 | | 2005 | 5 | 3 | 8 | | 2006 | 5 | 3 | 8 | | 2007 | 2 | 1 | 3 | | 2008 | 5 | 6 | 11 | | 2009 | 9 | 0 | 9 | | 2010 | 4 | 1 | 5 | | 2011 | 5 | 2 | 7 | | 2012 | 7 | 5 | 12 | | 2013 | 5 | 4 | 9 | | 2014 | 4 | 1 | 5 | | 2015 | 5 | 4 | 9 | | 2016 | 6 | 2 | 8 | | 2017 | 4 | 4 | 8 | | 2018 | 9 | 6 | 15 | | 2019 | 7 | 4 | 11 | | 2020 | 6 | 6 | 12 | | 2021 | 9 | 4 | 13 | | 2022 | 2 | 4 | 6 | | 2023 | 1 | 5 | 6 | | 2024 | 7 | 8 | 15 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Eosinophils" by people in Profiles.
-
Kharitonova EV, Sun Q, Ockerman F, Chen B, Zhou LY, Hysong MR, Tuftin B, Cao H, Mathias RA, Auer PL, Ober C, Raffield LM, Reiner AP, Cox NJ, Kelada SNP, Tao R, Li Y. EndoPRS: Incorporating endophenotype information to improve polygenic risk scores for clinical endpoints-A study in asthma. Am J Hum Genet. 2025 May 01; 112(5):1199-1214.
-
Ackerman SJ, Kagalwalla AF, Pan Z, Wechsler J, Keeley K, Gonsalves N, Hirano I, Zalewski A, Menard-Katcher P, Menard-Katcher C, Gupta SK, Chauhan N, Grozdanovic M, Atkins D, Nguyen N, Furuta GT. The Minimally Invasive 1-Hour Esophageal String Test Monitors Therapeutic Changes in Mucosal Inflammation in Eosinophilic Esophagitis. Am J Gastroenterol. 2025 Jan 01; 120(1):254-258.
-
Haruna NF, Politanska Y, Connelly AR, O'Connor K, Bhattacharya S, Miklaszewski GE, P?rez-Leonor XG, Rerko G, Hentenaar IT, Nguyen DC, Lamothe Molina PA, Bochner BS, Abdala-Valencia H, Gill MA, Lee FE, Berdnikovs S. scRNA-seq profiling of human granulocytes reveals expansion of developmentally flexible neutrophil precursors with mixed neutrophil and eosinophil properties in asthma. J Leukoc Biol. 2024 Nov 04; 116(5):1184-1197.
-
Gauvreau GM, Sehmi R, FitzGerald JM, Leigh R, Cockcroft DW, Davis BE, Mayers I, Boulet LP, Al-Sajee D, Salter BM, Cusack RP, Ho T, Whetstone CE, Alsaji N, Satia I, Killian KJ, Mitchell PD, Magee IP, Bergeron C, Bhutani M, Werkstr?m V, Durzynski T, Shoemaker K, Katial RK, Jison M, Newbold P, McCrae C, O'Byrne PM. Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial. Eur Respir J. 2024 Sep; 64(3).
-
Schaunaman N, Nichols T, Cervantes D, Hartsoe P, Ferrington DA, Chu HW. The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice. Viruses. 2024 Aug 29; 16(9).
-
Wright BL, Abonia JP, Abud EM, Aceves SS, Ackerman SJ, Braskett M, Chang JW, Chehade M, Constantine GM, Davis CM, Dellon ES, Doyle AD, Durban R, Hill DA, Jensen ET, Kewalramani A, Khoury P, Klion AD, Kottyan L, Kuang FL, McGowan EC, Ruffner MA, Spencer LA, Spergel JM, Uchida AM, Wechsler JB, Pesek RD. Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting. J Allergy Clin Immunol. 2024 Oct; 154(4):882-892.
-
Khoury P, Roufosse F, Kuang FL, Ackerman SJ, Akuthota P, Bochner BS, Johansson MW, Mathur SK, Ogbogu PU, Spencer LA, Wechsler ME, Zimmermann N, Klion AD. Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities. J Leukoc Biol. 2024 Jul 25; 116(2):307-320.
-
Haruna NF, Berdnikovs S, Nie Z. Eosinophil biology from the standpoint of metabolism: implications for metabolic disorders and asthma. J Leukoc Biol. 2024 Jul 25; 116(2):288-296.
-
Schworer SA, Olbrich CL, Larsen LD, Howard E, Liu L, Koyama K, Spencer LA. Notch 2 signaling contributes to intestinal eosinophil adaptations in steady state and tissue burden following oral allergen challenge. J Leukoc Biol. 2024 Jul 25; 116(2):379-391.
-
Jackson DJ, Pelaia G, Emmanuel B, Tran TN, Cohen D, Shih VH, Shavit A, Arbetter D, Katial R, Rabe APJ, Garcia Gil E, Pardal M, Nuevo J, Watt M, Boarino S, Kayaniyil S, Chaves Loureiro C, Padilla-Galo A, Nair P. Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme. Eur Respir J. 2024 Jul; 64(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|